BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27465894)

  • 1. Testosterone Aromatization to Estradiol in Course of Ovarian Functioning Brenner Tumor Associated With Endometrial Carcinoma and Endometriosis (Roncati-Manenti Triad).
    Roncati L; Manenti A; Pusiol T; Piscioli F; Barbolini G; Maiorana A
    Int J Gynecol Cancer; 2016 Oct; 26(8):1461-4. PubMed ID: 27465894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens.
    Chapel DB; Yamada SD; Cowan M; Lastra RR
    Gynecol Oncol; 2018 Jun; 149(3):570-574. PubMed ID: 29656794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian tumors with functioning stroma: a clinicopathologic study with special reference to serum estrogen level, stromal morphology, and aromatase expression.
    Kato N; Hayasaka T; Takeda J; Osakabe M; Kurachi H
    Int J Gynecol Pathol; 2013 Nov; 32(6):556-61. PubMed ID: 24071871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.
    Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M
    Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral Brenner tumor with endometrial adenocarcinoma in a postmenopausal woman.
    Indraccolo U; Cingolani N; Indraccolo SR
    Eur J Gynaecol Oncol; 2007; 28(3):233-4. PubMed ID: 17624095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androstenedione up-regulation of endometrial aromatase expression via local conversion to estrogen: potential relevance to the pathogenesis of endometriosis.
    Bukulmez O; Hardy DB; Carr BR; Auchus RJ; Toloubeydokhti T; Word RA; Mendelson CR
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3471-7. PubMed ID: 18559914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.
    Ramalingam P; Masand RP; Euscher ED; Malpica A
    Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.
    Takai N; Kai K; Tsuno A; Nasu K; Kashima K; Narahara H
    Arch Gynecol Obstet; 2011 Oct; 284(4):951-5. PubMed ID: 21046134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report of a malignant Brenner tumor with hyperestrogenism.
    Joh K; Aizawa S; Ohkawa K; Dohzono H; Aida S; Ohgoshi E
    Pathol Int; 1995 Jan; 45(1):75-84. PubMed ID: 7704247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers.
    Kobayashi Y; Nakamura K; Nomura H; Banno K; Irie H; Adachi M; Iida M; Umene K; Nogami Y; Masuda K; Kisu I; Ueki A; Yamagami W; Kataoka F; Hirasawa A; Tominaga E; Susumu N; Aoki D
    Int J Gynecol Cancer; 2015 Mar; 25(3):440-6. PubMed ID: 25695547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen synthesizing rare malignant Brenner tumor of the ovary with the presence of progesterone and androgen receptors in the absence of estrogen receptors.
    Kühnel R; Rao BR; Stolk JG; van Kessel H; Seldenrijk CA; Willig AP
    Gynecol Oncol; 1987 Feb; 26(2):263-9. PubMed ID: 3804043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosis.
    Stewart CJ; Walsh MD; Budgeon CA; Crook ML; Buchanan DB
    Pathology; 2013 Oct; 45(6):559-66. PubMed ID: 24018808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
    Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of a borderline Brenner tumor associated with bilateral serous cystadenoma and endometrial carcinoma.
    Cruz-Galarza D; Pérez-Rodríguez O; Laboy-Torres J; Gutiérrez-Rivera S
    Bol Asoc Med P R; 2014; 106(1):54-6. PubMed ID: 24791367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human growth hormone and interleukin-6 are upregulated in endometriosis and endometrioid adenocarcinoma.
    Slater M; Cooper M; Murphy CR
    Acta Histochem; 2006; 108(1):13-8. PubMed ID: 16564564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cytoskeletal proteins alpha-actinin, Ezrin, and talin are De-expressed in endometriosis and endometrioid carcinoma compared with normal uterine epithelium.
    Slater M; Cooper M; Murphy CR
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):170-4. PubMed ID: 17525629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
    Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
    Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.